APIs

Zhejiang Hengkang Pharmaceutical Co., Ltd.
浙江恒康药业股份有限公司
Commercial API List
| API Names | Indication | Specifications | Regulatory |
| Acemetacin | NSAID | EP | CEP/WC |
| Ademetionine1 , 4 – Butanedisulfonate | Liver Protection | IN HOUSE | DMF/WC |
| Amiodarone HCl | Antiarrhythmic | EP/USP | CEP/WC |
| Benserazide HCl | Antiparkinsonian | EP | CEP/EU GMP/WC |
| Bilastine | Antihistamines | IN HOUSE | DMF IN PROCESS |
| Carbocisteine | Expectorants | EP | DMF IN PROCESS |
| Carbocisteine Lysine Salt | Expectorants | IN HOUSE | DMF/WC |
| Ciprofibrate | Hyperlipidemia | EP | DMF |
| Deferasirox | Iron Chelating Agent | EP | CEP/EU GMP |
| Dotinurad | Hyperuricemia | IN HOUSE | DMF IN PROCESS |
| Eltrombopag Olamine | Thrombocytopenia | IN HOUSE | US DMF#: 040357/WC |
| Esmolol HCl | Antiarrhythmic | USP | DMF |
| Etravirine | Anti – HIV | IN HOUSE | DMF |
| Favipiravir | Antiviral | IN HOUSE | DMF |
| Fenofibrate | Hyperlipidemia | EP/ USP | DMF |
| Heparinoid | Thrombophlebitis | JP | DMF |
| Iguratimod | Antirheumatic | IN HOUSE | DMF |
| Ilaprazole Base / Sodium | GRED | IN HOUSE | DMF |
| Mesalazine / Mesalamine | Ulcerative Colitis/ Crohn’ s | EP/ USP | US DMF#: 037319/CEPUS FDA/EU GMP/WC |
| Mirabegron | Overactive Bladder | IN HOUSE | DMF/EU GMP |
| Otilonium Bromide | Spasmolytic | IN HOUSE | DMF |
| Perampanel | Antiepileptic | IN HOUSE | DMF IN PROCESS |
| Pranlukast Hydrate | Bronchial Asthma | JP | DMF |
| Riociguat | CTEPH | IN HOUSE | DMF |
| Roxadustat | HIF – PHI | IN HOUSE | DMF IN PROCESS |
| Safinamide Mesylate | Antiparkinsonian | IN HOUSE | DMF |
| Saxagliptin Monohydrate | Diabetes | IN HOUSE | DMF |
| Saxagliptin HCl | Diabetes | IN HOUSE | DMF |
| Tauroursodeoxycholic Acid | PBC, PSC, NAFLD | IN HOUSE | DMF |
| Tenoxicam | NSAID | EP | CEP/WC |
| Tofacitinib Citrate | Atopic Dermatitis | IN HOUSE | DMF IN PROCESS |
| Upadacitinib | Atopic Dermatitis | IN HOUSE | DMF |
| Vancomycin HCl | Antibiotic | EP/USP/JP | DMF/WC |
| Vonoprazan Fumarate | GRED | IN HOUSE | USDMF#: 040356 EU GMP |
| NOTE: 1) The products are not for patents covered area or countries. 2) The most intermediates are available for listed APIs. |
